Procaps Group SA (PROC): Fair Value Consensus

Corporate company logo of Procaps Group (PROC)

Procaps Group S.A. (PROC) faces pricing pressure from major Asian manufacturing hubs within the consolidated Latin American sector. Revenue stability is sustained by exclusive capsule formulas that lock in B2B clients for years. Process optimization is being driven by AI logistics and autonomous transport, as conveyor automation has reached its limit. The current metric stands at 0.00, and the market capitalization trend is presented below.

PROC Procaps Analyst Consensus Forecast (07/04/2022 - 02/16/2025)
Flagship merchandise of Procaps Group Corp

The arithmetic mean of target prices from sector analysts reflects the aggregated fundamental value of assets and the business's discounted cash flows. For Procaps Group S.A. (PROC), the history of the consensus target price illustrates how the efficiency of outsourcing production and logistics to external partners influences market expectations, transforming the holding's operational flexibility into a long-term capitalization vector.

Competitors of Procaps Group S.A.

HLN: Forecast Levels Chart|Price Target Chart Kenvue KVUE|Fair Value Consensus VRNA|MENS - Price Target Chart|Average Forecast Price Ligand Corp|AMRX: Analyst Consensus Forecast|Consensus Target perrigo.com|Price Target Chart Alvotech SA|Liquidia Corp - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals Corp) - Fair Value Consensus|Analyst Consensus Forecast MNKD (MannKind Corporation)|Analyst Consensus Forecast amphastar.com AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Price Target Chart|Consensus Target Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic|Consensus Target TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Fair Value Consensus|Price Target Chart Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Average Forecast Price|EXOZ: Consensus Target|Oramed Pharmaceuticals - Analyst Forecast Prices|ENTX: Analyst Consensus Forecast|MindWalk Holdings, Inc. - Fair Value Consensus|ABVC (ABVC BioPharma Inc) - Analyst Consensus Forecast|Average Forecast Price Cumberland Corp CPIX|Price Target Chart Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Fair Value Consensus|Price Target Chart Telomir Pharmaceuticals, Inc. TELO|RANI (Rani Therapeutics Holdings) - Forecast Levels Chart|SNYR - Price Target Chart|Fair Value Consensus RLYB (Rallybio Corporation)|lexariabioscience.com (LEXX) - Price Target Chart|Average Forecast Price pulmatrix.com (PULM)|PTHL (Pheton Holdings Limited) - Analyst Consensus Forecast|Consensus Target Aptorum (APM)|Analyst Consensus Forecast LYRA|Analyst Consensus Forecast impactbiomedinc.com (IBO)|Price Target Chart TNF Pharmaceuticals, Inc. TNFA|YCBD (cbdMD Inc.) - Forecast Levels Chart|PRFX - Price Target Chart|Analyst Median Target Altamira Therapeutics CYTO|LIPO (Lipella) - Consensus Target|OptiNose Corp - Fair Value Consensus|PIRS (Pieris Pharmaceuticals) - Analyst Consensus Forecast|PTPI - Analyst Target Range|Price Target Chart Qilian International Holding (QLI)|SLRN (Acelyrin Inc.) - Fair Value Consensus|Price Target Chart TFF Pharma TFFP